We also found a significant increase in the serum levels of IL-6 in patients with anti-PD-1 antibody-induced psoriasis-like dermatitis, as we had shown in our preliminary study25, indicating that IL-6 could play an important role during disease development and thus, may be a suitable treatment target. This evidence concerns the gene PDCD1 and dermatitis.